NCT00957606 Osteoporosis Among Men Treated With Androgen Deprivation for Prostate Cancer Status UNKNOWN Phase PHASE3
NCT00949611 Wiser Choices in Osteoporosis Choice II: A Decision Aid for Patients and Clinicians Status COMPLETED Phase NA
NCT00939874 Switch From Tenofovir to Raltegravir for Low Bone Mineral Density Status COMPLETED Phase PHASE4
NCT00936260 Drug Holidays in the Treatment With Alendronate in Postmenopausal Women With Osteoporosis Status COMPLETED Phase NA
NCT00926380 Denosumab, Teriparatide or Both for the Treatment of Postmenopausal Osteoporosis Status COMPLETED Phase PHASE2
NCT00925600 Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Status COMPLETED Phase PHASE3
NCT00919711 Study to Evaluate the Safety and Efficacy of Denosumab and Actonel® in Post Menopausal Women Transitioned From Alendronate Therapy Status COMPLETED Phase PHASE3
NCT00903344 Impact of Vitamin D Supplementation on Lactation Associated Bone Loss Status COMPLETED Phase NA
NCT00899288 Fingernails in Evaluating Bone Health in Postmenopausal Women With Breast Cancer Undergoing Hormone Therapy on Clinical Trial IBCSG-1-98 Status TERMINATED Phase PHASE3
NCT00890981 A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With Denosumab Status COMPLETED Phase PHASE3
NCT00887965 A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab Status COMPLETED Phase PHASE2
NCT00887354 A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture Status COMPLETED Phase PHASE4
NCT00885170 A Study to Evaluate the Safety, Tolerability, and Efficacy of Odanacatib (MK-0822) in Postmenopausal Women Previously Treated With a Bisphosphonate (MK-0822-042) Status COMPLETED Phase PHASE2
NCT00877097 Effects of Continuous Combined Hormone Replacement Therapy and Clodronate on Bone Mineral Density (BMD) in Osteoporotic Women Status COMPLETED Phase NA
NCT00863590 A Single-Dose Study of the Safety, Tolerability, and Pharmacokinetics of Odanacatib (MK0822) in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00863525 A Study to Assess the Effects of a Light Breakfast on the Safety, Tolerability, and Pharmacokinetics of Odanacatib (MK0822) Status COMPLETED Phase PHASE1
NCT00860964 A Study of Prevention and Treatment of Postmenopausal Osteoporosis in Chinese Women Status COMPLETED Phase PHASE4